Zimmer Biomet (ZBH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $94.38, +2.84% vs the prior close of $91.77.
- Volume 1.86M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ZBH rises 2.8% to $94.38. Closed at $94.38, +2.84% vs the prior close of $91.77. Day range $93.23–$94.85, opened at $93.56.
ZBH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ZBH rises 2.8% to $94.38
- Closed at $94.38, +2.84% vs the prior close of $91.77. Day range $93.23–$94.85, opened at $93.56.
- Volume was 1.86M shares, 0.9x its 50-day average of 2.07M.
- Price is -1.0% vs its 50-day average ($95.32) and +3.3% vs its 200-day average ($91.37).
- 52-week range $79.12–$106.88; today's close sits at 55% of that range, 11.7% below the 52-week high.
Oct 14, 2026 — ZBH dips 0.3% to $91.77
- Closed at $91.77, -0.34% vs the prior close of $92.08. Day range $90.65–$92.61, opened at $92.20.
- Volume was 1.89M shares, 0.9x its 50-day average of 2.10M.
- Price is -3.8% vs its 50-day average ($95.40) and +0.5% vs its 200-day average ($91.35).
- 52-week range $79.12–$106.88; today's close sits at 46% of that range, 14.1% below the 52-week high.
Oct 13, 2026 — ZBH ends flat (-0.1%) to $92.08
- Closed at $92.08, -0.10% vs the prior close of $92.17. Day range $91.39–$93.85, opened at $92.87.
- Volume was 2.30M shares, 1.1x its 50-day average of 2.10M.
- Price is -3.6% vs its 50-day average ($95.48) and +0.8% vs its 200-day average ($91.34).
- 52-week range $79.12–$106.88; today's close sits at 47% of that range, 13.8% below the 52-week high.
Oct 12, 2026 — ZBH jumps 3.4% to $92.17, 3 up days in a row
- Closed at $92.17, +3.40% vs the prior close of $89.14. Day range $89.18–$92.23, opened at $89.28.
- Volume was 1.80M shares, 0.8x its 50-day average of 2.12M.
- Price is -3.6% vs its 50-day average ($95.58) and +0.9% vs its 200-day average ($91.33).
- 52-week range $79.12–$106.88; today's close sits at 47% of that range, 13.8% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — ZBH ends flat (+0.3%) to $89.14
- Closed at $89.14, +0.29% vs the prior close of $88.88. Day range $88.40–$90.21, opened at $88.93.
- Volume was 1.60M shares, 0.8x its 50-day average of 2.13M.
- Price is -6.8% vs its 50-day average ($95.61) and -2.4% vs its 200-day average ($91.32).
- 52-week range $79.12–$106.88; today's close sits at 36% of that range, 16.6% below the 52-week high.
Oct 8, 2026 — ZBH rises 0.4% to $88.88
- Closed at $88.88, +0.44% vs the prior close of $88.49. Day range $87.31–$89.07, opened at $88.36.
- Volume was 2.51M shares, 1.2x its 50-day average of 2.15M.
- Price is -7.2% vs its 50-day average ($95.73) and -2.7% vs its 200-day average ($91.32).
- 52-week range $79.12–$106.88; today's close sits at 35% of that range, 16.8% below the 52-week high.
Oct 7, 2026 — ZBH dips 1.3% to $88.49
- Closed at $88.49, -1.33% vs the prior close of $89.68. Day range $88.32–$90.01, opened at $89.11.
- Volume was 1.99M shares, 0.9x its 50-day average of 2.19M.
- Price is -7.7% vs its 50-day average ($95.89) and -3.1% vs its 200-day average ($91.32).
- 52-week range $79.12–$106.88; today's close sits at 34% of that range, 17.2% below the 52-week high.
Oct 6, 2026 — ZBH dips 2.1% to $89.68
- Closed at $89.68, -2.06% vs the prior close of $91.57. Day range $89.55–$91.95, opened at $91.41.
- Volume was 1.68M shares, 0.8x its 50-day average of 2.18M.
- Price is -6.6% vs its 50-day average ($96.04) and -1.8% vs its 200-day average ($91.33).
- 52-week range $79.12–$106.88; today's close sits at 38% of that range, 16.1% below the 52-week high.
Oct 5, 2026 — ZBH jumps 3.7% to $91.57
- Closed at $91.57, +3.72% vs the prior close of $88.29. Day range $88.23–$92.03, opened at $89.02.
- Volume was 2.29M shares, 1.1x its 50-day average of 2.16M.
- Price is -4.7% vs its 50-day average ($96.09) and +0.3% vs its 200-day average ($91.34).
- 52-week range $79.12–$106.88; today's close sits at 45% of that range, 14.3% below the 52-week high.
Oct 2, 2026 — ZBH ends flat (+0.3%) to $88.29
- Closed at $88.29, +0.26% vs the prior close of $88.06. Day range $87.11–$88.81, opened at $88.13.
- Volume was 1.99M shares, 0.9x its 50-day average of 2.16M.
- Price is -8.1% vs its 50-day average ($96.08) and -3.3% vs its 200-day average ($91.34).
- 52-week range $79.12–$106.88; today's close sits at 33% of that range, 17.4% below the 52-week high.
ZBH latest news & SEC filings
Every SEC filing by or about ZBH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Campbell Gary Craig converted options/RSUs into 2,368 shares on Oct 1, 2026; now holds 2,368
- Campbell Gary Craig had withheld for taxes 932 shares at $88.42 (≈$82.41K) on Oct 1, 2026; now holds 1,436
- Campbell Gary Craig converted options/RSUs into 1,218 shares on Oct 1, 2026; now holds 2,654
- Campbell Gary Craig had withheld for taxes 480 shares at $88.42 (≈$42.44K) on Oct 1, 2026; now holds 2,174
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 5, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.18B (prior year $2.08B) (+4.8% vs Jun 30, 2025)
- Net income: $198.30M (prior year $152.80M) (+29.8% vs Jun 30, 2025)
- Diluted EPS: $1.03 (prior year $0.77) (+33.8% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Things to know before you trade ZBH
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: Apr 28, 2026, Feb 10, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.40% (largest 3.7%).
- Liquidity: about 2.13M shares (≈$200.73M) trade per day on average.
- 52-week position: $94.38 vs a range of $79.12–$106.88 (55% of the range).
- Dividends: last ex-dividend date Sep 30, 2026 ($0.24/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 6 sales; latest: Kevin R Thornal sold 5,691 shares on Sep 11, 2026.
- Latest filings: 8-K Sep 8, 2026; 8-K Aug 5, 2026; 10-Q Aug 5, 2026.
- Share count: 190.74M shares outstanding (Jul 30, 2026), -3.7% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
ZBH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 93.56 | 94.85 | 93.23 | 94.38 | 1.86M |
| Oct 14, 2026 | 92.20 | 92.61 | 90.65 | 91.77 | 1.89M |
| Oct 13, 2026 | 92.87 | 93.85 | 91.39 | 92.08 | 2.30M |
| Oct 12, 2026 | 89.28 | 92.23 | 89.18 | 92.17 | 1.80M |
| Oct 9, 2026 | 88.93 | 90.21 | 88.40 | 89.14 | 1.60M |
| Oct 8, 2026 | 88.36 | 89.07 | 87.31 | 88.88 | 2.51M |
| Oct 7, 2026 | 89.11 | 90.01 | 88.32 | 88.49 | 1.99M |
| Oct 6, 2026 | 91.41 | 91.95 | 89.55 | 89.68 | 1.68M |
| Oct 5, 2026 | 89.02 | 92.03 | 88.23 | 91.57 | 2.29M |
| Oct 2, 2026 | 88.13 | 88.81 | 87.11 | 88.29 | 1.99M |
| Oct 1, 2026 | 88.68 | 89.30 | 87.54 | 88.06 | 2.30M |
| Sep 30, 2026 | 90.82 | 90.87 | 88.82 | 88.83 | 2.58M |
| Sep 29, 2026 | 90.96 | 91.59 | 90.60 | 91.34 | 1.46M |
| Sep 28, 2026 | 90.76 | 91.84 | 90.09 | 91.62 | 1.63M |
| Sep 25, 2026 | 89.43 | 91.84 | 89.24 | 91.04 | 1.79M |
| Sep 24, 2026 | 91.43 | 92.51 | 89.02 | 89.69 | 2.65M |
| Sep 23, 2026 | 92.60 | 93.25 | 89.87 | 90.88 | 2.97M |
| Sep 22, 2026 | 95.43 | 95.47 | 93.36 | 93.98 | 1.71M |
| Sep 21, 2026 | 95.32 | 95.66 | 93.64 | 94.32 | 1.60M |
| Sep 18, 2026 | 94.04 | 96.17 | 93.72 | 95.36 | 3.95M |
About Zimmer Biomet
Zimmer Biomet (ZBH) is listed on the NYSE and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in WARSAW, IN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1136869.
ZBH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Betsy J Bernard | Director | May 27, 2026 |
| Michael J. Farrell | Director | Jul 2, 2026 |
| Robert Hagemann | Director | Jul 2, 2026 |
| Arthur J Higgins | Director | Jul 2, 2026 |
| Maria Teresa Hilado | Director | Jul 2, 2026 |
| Syed A. Jafry | Director | May 27, 2026 |
| Sreelakshmi Kolli | Director | Jul 2, 2026 |
| Devdatt Kurdikar | Director | Jul 2, 2026 |
| Louis Shapiro | Director | Jul 2, 2026 |
| Ivan Tornos | Chairman, President and CEO | Mar 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chintan Desai | President, APAC | Aug 5, 2026 |
| Jehanzeb Noor | See remarks below. | Jun 3, 2026 |
| Chad F Phipps | See remarks below. | Sep 9, 2026 |
| Paul A Stellato | VP, Controller, CAO | May 5, 2026 |
| Kevin R Thornal | Grp Pres-Global Business | Sep 15, 2026 |
| Ivan Tornos | Chairman, President and CEO | Mar 10, 2026 |
| Suketu Upadhyay | Exec VP, CFO | Mar 10, 2026 |
| Zuilen Wilfred Van | Group Pres, EMEA | Mar 10, 2026 |
| Lori Winkler | SVP and CHRO | Mar 16, 2026 |
| Sang Yi | Group President, Asia Pacific | Jun 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Kevin R Thornal | Sale | 5,691 | $92.95 |
| Sep 4, 2026 | Chad F Phipps | Sale | 3,000 | $98.35 |
| May 29, 2026 | Sang Yi | Sale | 4,200 | $82.64 |
| May 29, 2026 | Sang Yi | Sale | 800 | $82.66 |
| Mar 12, 2026 | Lori Winkler | Sale | 2,650 | $94.66 |
| Feb 12, 2026 | Sang Yi | Sale | 1,000 | $96.49 |
ZBH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $8.23B | $705.10M | 3.55 | $1.70B |
| Dec 31, 2024 | $7.68B | $903.80M | 4.43 | $1.50B |
| Dec 31, 2023 | $7.39B | $1.02B | 4.88 | $1.58B |
| Dec 31, 2022 | $6.94B | $231.40M | 1.10 | — |
| Dec 31, 2021 | $6.83B | $401.60M | 1.91 | $1.50B |
Latest balance sheet: total assets $22.80B, total liabilities $10.17B, cash $410.00M (as of Jun 30, 2026).
ZBH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $98.16 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $82.80 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $91.40 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $87.55 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $98.43 |
| May 5, 2025 | 8-K Item 2.02 (results) | $90.48 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $102.69 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $109.81 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Steris (STE)Align Technology (ALGN)Smith & Nephew (SNN)MSA Safety (MSA)Establishment Labs (ESTA)Enovis (ENOV)Cadre (CDRE)Sanara MedTech (SMTI)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ZBH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.